Two Seas Capital Lp Top Holdings and 13F Report (2025) About Two Seas Capital LpInvestment ActivityTwo Seas Capital Lp has $1.16 billion in total holdings as of December 31, 2024.Two Seas Capital Lp owns shares of 29 different stocks, but just 10 companies or ETFs make up 80% of its holdings.Approximately 46.94% of the portfolio was purchased this quarter.About 5.49% of the portfolio was sold this quarter.This quarter, Two Seas Capital Lp has purchased 25 new stocks and bought additional shares in 14 stocks.Two Seas Capital Lp sold shares of 4 stocks and completely divested from 4 stocks this quarter.Largest Holdings TALEN ENERGY CORP $185,045,158Indivior $154,846,899Roivant Sciences $120,285,157SPDR S&P 500 ETF Trust $117,216,000Invesco QQQ $101,734,770 Largest New Holdings this Quarter SPDR S&P 500 ETF Trust $117,216,000 HoldingInvesco QQQ $101,734,770 HoldingGannett $15,285,248 HoldingArdelyx $9,406,559 HoldingBitdeer Technologies Group $9,383,717 Holding Largest Purchases this Quarter SPDR S&P 500 ETF Trust 200,000 shares (about $117.22M)Invesco QQQ 199,000 shares (about $101.73M)TALEN ENERGY CORP 469,360 shares (about $94.56M)CALUMET INC 1,873,327 shares (about $41.25M)Sotera Health 2,496,136 shares (about $34.15M) Largest Sales this Quarter Meta Platforms 17,442 shares (about $10.21M)Indivior 572,513 shares (about $7.12M)Alphabet 15,000 shares (about $2.84M)Esperion Therapeutics 353,407 shares (about $777.50K) Sector Allocation Over TimeMap of 500 Largest Holdings ofTwo Seas Capital Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorTALEN ENERGY CORP$185,045,158$94,561,959 ▲104.5%918,47516.0%COMINDVIndivior$154,846,899$7,116,337 ▼-4.4%12,457,51413.4%MedicalROIVRoivant Sciences$120,285,157$5,239,673 ▲4.6%10,167,80710.4%MedicalSPYSPDR S&P 500 ETF Trust$117,216,000$117,216,000 ▲New Holding200,00010.1%FinanceQQQInvesco QQQ$101,734,770$101,734,770 ▲New Holding199,0008.8%FinanceCORE SCIENTIFIC INC NEW$87,572,076$7,405,713 ▲9.2%6,232,8887.6%COMVSTVistra$52,264,449$17,429,388 ▲50.0%379,0854.5%UtilitiesCALUMET INC$48,077,015$41,250,661 ▲604.3%2,183,3344.2%COMAVADEL PHARMACEUTICALS PLC$45,155,679$21,468,451 ▲90.6%4,296,4493.9%COM SHSSHCSotera Health$39,619,140$34,147,140 ▲624.0%2,896,1363.4%MedicalIMVTImmunovant$37,442,679$20,682,950 ▲123.4%1,511,6143.2%MedicalABUSArbutus Biopharma$28,582,926$1,156,167 ▲4.2%8,740,9562.5%MedicalCEGConstellation Energy$22,027,158$16,434,408 ▲293.9%98,4631.9%Oils/EnergyGCIGannett$15,285,248$15,285,248 ▲New Holding3,020,8001.3%Business ServicesESPREsperion Therapeutics$13,707,916$777,495 ▼-5.4%6,230,8711.2%MedicalMETAMeta Platforms$10,841,303$10,212,465 ▼-48.5%18,5160.9%Computer and TechnologyHUT 8 CORP$9,769,796$5,571,067 ▲132.7%476,8080.8%COMARDXArdelyx$9,406,559$9,406,559 ▲New Holding1,855,3370.8%MedicalBTDRBitdeer Technologies Group$9,383,717$9,383,717 ▲New Holding433,0280.8%Business ServicesIRENIris Energy$8,445,200$5,744,700 ▲212.7%860,0000.7%Oils/EnergyADAPAdaptimmune Therapeutics$7,991,693$7,991,693 ▲New Holding14,835,1460.7%MedicalSONOSonos$7,955,0770.0%528,9280.7%Consumer DiscretionaryESPERION THERAPEUTICS INC NE$5,162,1940.0%5,315,0000.4%NOTE 4.000%11/1APLDApplied Digital$5,062,165$5,062,165 ▲New Holding662,5870.4%FinanceGOOGLAlphabet$4,732,500$2,839,500 ▼-37.5%25,0000.4%Computer and TechnologySABLE OFFSHORE CORP$3,630,062$3,630,062 ▲New Holding158,5180.3%COM SHSCORE SCIENTIFIC INC NEW$2,312,0460.0%280,2480.2%*W EXP 01/23/202BTBTBit Digital$1,940,873$732,500 ▲60.6%662,4140.2%Business ServicesOMEXOdyssey Marine Exploration$1,835,315$1,763,315 ▲2,449.0%2,549,0490.2%TransportationEXELExelixis$0$35,318,028 ▼-100.0%00.0%MedicalARQTArcutis Biotherapeutics$0$2,902,735 ▼-100.0%00.0%MedicalPCRXPacira BioSciences$0$2,383,920 ▼-100.0%00.0%MedicalWULFTeraWulf$0$2,024,690 ▼-100.0%00.0%FinanceShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
